Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2018

01-06-2018 | Mgmt. of Complex Cases in GI Oncology

Surgico-pathological Outcomes of 148 Radical Cholecystectomies Using Systematic Regional Lymphadenectomy Protocol: a Retrospective Study

Authors: Durgatosh Pandey, Pankaj Kumar Garg, Ashish Jakhetiya, Neelesh Jain, Shreyash Rai

Published in: Journal of Gastrointestinal Cancer | Issue 2/2018

Login to get access

Excerpt

Gallbladder cancer (GBC) is a potentially lethal malignancy among the biliary tract cancers with abysmal long-term survival. Surgery is the only curative treatment available for the management of GBC and, presently, provides the only ray of hope for long-term survival [1, 2]. Lymph node (LN) involvement is an important prognostic factor in GBC; lymphadenectomy is an indispensable part of radical resection [3]. American Joint Committee on Cancer 7th edition TNM staging for gallbladder cancer describes N1 nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein and N2 nodes as periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes [4]. AJCC staging manual further stages the presence of N2 nodes as stage IV disease; this nihilism has given rise to a marked controversy in the role and extent of lymphadenectomy. Though a number of studies have highlighted that the lymphadenectomy is associated with improved survival after surgery in GBC [57], literature is still not clear whether the total number of LNs retrieved, number of metastatic LNs, or their ratio or the location of LNs correlates with survival [8]. We believe that a systematic approach to regional lymphadenectomy is essential to maximize the lymph node yield based on the sound principles of surgical oncology. The present study shares our experience of radical cholecystectomies using a systematic regional lymphadenectomy protocol in a large cohort of patients with GBC. …
Literature
1.
go back to reference Pandey D, Garg PK, Manjunath NML, Sharma J. Extra-hepatic bile duct resection: an insight in the management of gallbladder cancer. J Gastrointest Cancer. 2015;46:291–6.CrossRefPubMed Pandey D, Garg PK, Manjunath NML, Sharma J. Extra-hepatic bile duct resection: an insight in the management of gallbladder cancer. J Gastrointest Cancer. 2015;46:291–6.CrossRefPubMed
2.
go back to reference Garg PK, Pandey D. Gallbladder cancer: nihilism abates, optimism prevails. Eur J Surg Oncol. 2015;41:1443.CrossRefPubMed Garg PK, Pandey D. Gallbladder cancer: nihilism abates, optimism prevails. Eur J Surg Oncol. 2015;41:1443.CrossRefPubMed
3.
go back to reference Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol. 2015;9:155–66.CrossRefPubMed Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol. 2015;9:155–66.CrossRefPubMed
4.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A editors. Gallbladder. In: AJCC cancer staging manual. Seventh edition. New York: Springer; p. 211–7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A editors. Gallbladder. In: AJCC cancer staging manual. Seventh edition. New York: Springer; p. 211–7.
5.
go back to reference Jensen EH, Abraham A, Jarosek S, Habermann EB, al-Refaie WB, Vickers SA, et al. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery. 2009;146:706–11.CrossRefPubMed Jensen EH, Abraham A, Jarosek S, Habermann EB, al-Refaie WB, Vickers SA, et al. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery. 2009;146:706–11.CrossRefPubMed
6.
go back to reference Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, et al. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010;14:1578–91.CrossRefPubMed Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, et al. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010;14:1578–91.CrossRefPubMed
7.
go back to reference Downing SR, Cadogan K-A, Ortega G, Oyetunji TA, Siram SM, Chang DC, et al. Early-stage gallbladder cancer in the surveillance, epidemiology, and end results database: effect of extended surgical resection. Arch Surg. 2011;146:734–8.CrossRefPubMed Downing SR, Cadogan K-A, Ortega G, Oyetunji TA, Siram SM, Chang DC, et al. Early-stage gallbladder cancer in the surveillance, epidemiology, and end results database: effect of extended surgical resection. Arch Surg. 2011;146:734–8.CrossRefPubMed
8.
go back to reference Kim SH, Chong JU, Lim JH, Choi GH, Kang CM, Choi JS, et al. Optimal assessment of lymph node status in gallbladder cancer. Eur J Surg Oncol. 2016;42:205–10.CrossRefPubMed Kim SH, Chong JU, Lim JH, Choi GH, Kang CM, Choi JS, et al. Optimal assessment of lymph node status in gallbladder cancer. Eur J Surg Oncol. 2016;42:205–10.CrossRefPubMed
9.
go back to reference Pandey D. Technical description of a regional lymphadenectomy in radical surgery for gallbladder cancer. HPB (Oxford). 2012;14:216–9.CrossRef Pandey D. Technical description of a regional lymphadenectomy in radical surgery for gallbladder cancer. HPB (Oxford). 2012;14:216–9.CrossRef
11.
go back to reference Sakata J, Shirai Y, Wakai T, Ajioka Y, Hatakeyama K. Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol. 2010;17:1831–40.CrossRefPubMed Sakata J, Shirai Y, Wakai T, Ajioka Y, Hatakeyama K. Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol. 2010;17:1831–40.CrossRefPubMed
12.
go back to reference Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. World J Surg Oncol. 2012;10:87.CrossRefPubMedPubMedCentral Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. World J Surg Oncol. 2012;10:87.CrossRefPubMedPubMedCentral
13.
go back to reference Negi SS, Singh A, Chaudhary A. Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio? J Gastrointest Surg. 2011;15:1017–25.CrossRefPubMed Negi SS, Singh A, Chaudhary A. Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio? J Gastrointest Surg. 2011;15:1017–25.CrossRefPubMed
14.
go back to reference Shirai Y, Yoshida K, Tsukada K, Ohtani T, Muto T. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg. 1992;79:659–62.CrossRefPubMed Shirai Y, Yoshida K, Tsukada K, Ohtani T, Muto T. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg. 1992;79:659–62.CrossRefPubMed
Metadata
Title
Surgico-pathological Outcomes of 148 Radical Cholecystectomies Using Systematic Regional Lymphadenectomy Protocol: a Retrospective Study
Authors
Durgatosh Pandey
Pankaj Kumar Garg
Ashish Jakhetiya
Neelesh Jain
Shreyash Rai
Publication date
01-06-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2018
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0106-3

Other articles of this Issue 2/2018

Journal of Gastrointestinal Cancer 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.